Emily K. Bergsland

MD

Director, Center for Neuroendocrine Tumors
Gastrointestinal oncologist

Dr. Emily Bergsland is a gastrointestinal oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center and the director of the UCSF Center for Neuroendocrine Tumors. She specializes in the multidisciplinary care of patients with neuroendocrine cancers.

Bergsland's research is focused on better understanding why neuroendocrine tumors develop, identifying and testing new therapies, and improving outcomes in affected patients.

Bergsland earned her medical degree at the University of Minnesota, then completed a residency in internal medicine and fellowship in medical oncology at UCSF.

  • Education

    University of Minnesota, 1989

  • Residencies

    UCSF, Internal Medicine, 1992

  • Fellowships

    UCSF, Medical Oncology, 1995

  • Board Certifications

    Medical Oncology, American Board of Internal Medicine

  • Academic Title

    Professor

Conditions I specialize in

Clinics I work with

View map

Center for Neuroendocrine Tumors

Bakar Precision Cancer Medicine Building

1825 Fourth St.
San Francisco, CA 94158

(415) 476-2212
M-F, 8:30 a.m. - 5 p.m.

Gastrointestinal Medical Oncology Clinic

Bakar Precision Cancer Medicine Building

1825 Fourth St., Fourth Floor
San Francisco, CA 94158

(415) 353-9888
M-F, 8 a.m. - 5 p.m.

My reviews

4.9

Overall Experience
241 Reviews
Explained things in a way that was easy to understand
241 Reviews
Did the doctor pay attention to your concerns
240 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
237 Reviews
Knew the important information about your medical history
240 Reviews
The provider showed respect for what you had to say
238 Reviews
The provider spent enough time with me
240 Reviews
Read all reviews About our process

Selected research

Decorative Caduceus

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Will be assessed per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 determined by retrospective independent central review. Will be compared between treatment arms using the stratified log rank test at one-sided level 0...

Recruiting

Contact me

Providers on my team

Share